Pharmaco - Press Releases

Date	Title	Company
15-Jul-2021	MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology	MorphoSys AG
15-Jul-2021	Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuros’s license agreement with Checkmate Pharmaceuticals	Kuros Biosciences AG
15-Jul-2021	Christian Ullrich joins Straumann Group’s Executive Management Board as the new Group Chief Information Officer	Straumann Holding AG
14-Jul-2021	Drägerwerk AG & Co. KGaA: Business development in the first half year significantly above prior year despite lower earnings in the second quarter	Drägerwerk AG & Co. KGaA
14-Jul-2021	Medacta Announces Successful Completion of First Reverse Shoulder Arthroplasties using NextAR Augmented Reality Surgical Platform	Medacta Group SA
14-Jul-2021	AEVIS VICTORIA SA: Resignation from the Board of Directors	AEVIS VICTORIA SA
14-Jul-2021	Ligand-based technologies integrated into Flare™ V5 offer a comprehensive molecule design solution for drug discovery research chemists	Cresset
14-Jul-2021	Aptamer Group partners with top five global pharmaceutical company to support innovative vaccine development	Aptamer Group
14-Jul-2021	Immutep Quarterly Activities Report & Appendix 4C	Immutep Limited
14-Jul-2021	Novartis BIOME UK announces selection for the HealthHub 21 Challenge, in collaboration with KQ Labs and LifeArc	Novartis UK
14-Jul-2021	Grünenthal GmbH: Grünenthal secures long-term financing for growth strategy	Grünenthal GmbH
13-Jul-2021	Exclusive Interview Released: Richard Denk, SKAN AG: Co-chair and speaker at SMi’s Aseptic Processing Conference	SMi Group
13-Jul-2021	AEVIS VICTORIA SA: Authorized capital increase in execution of the acquisition of Klinik Pyramide am See AG	AEVIS VICTORIA SA
13-Jul-2021	Laevoroc Oncology Unveils Immunology Subsidiary with CSO Shanta Bantia to Develop PNP Inhibitor for Eradication of Relapsed Leukemia	Laevoroc Oncology
13-Jul-2021	PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors	PureTech
13-Jul-2021	Elekta optimizes treatment times for cancer patients via proactive service innovation	Elekta
13-Jul-2021	Thornton & Ross Ltd. (part of the STADA Group) enters UK respiratory market with Fixkoh Airmaster™ launch	Thornton & Ross Ltd
13-Jul-2021	Almac Group’s Charnwood Site Achieves Globally Recognised Health & Safety and Environmental Management System Certifications	Almac Group
13-Jul-2021	Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC	Novasep
13-Jul-2021	4D pharma announces publication of preclinical research showing single strain Megasphaera Massiliensis improves activity of CAR-T	4D pharma